Natera NTRA 深 滬
已收盤 08-07 16:00:00 美东时间
322.10
+56.720
+21.37%
華盛通- 最 高323.0099
- 今 開320.90
- 成交量 338.69万股
- 最 低 306.3796
- 昨 收 265.38
- 總市值 461.30亿
- 52周最高 323.0099
- 市盈率 靜 --
- 換手率 2.36%
- 52周最低 156.71
- 委 比 60.85%
- 總股本 1.43亿
- 歷史最高 323.0099
- 量 比 2.38
- 振 幅 6.27%
- 歷史最低 6.52
- 每 手 1
- 風險率 32.17%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Natera, Doximity, PubMatic, Airbnb And Other Big Stocks Moving Higher On Friday
U.S. stocks were higher, with the Nasdaq Composite gaining around 1% on Friday. Shares of Natera Inc (NASDAQ:NTRA) rose sharply after the company reported better-than-expected quarterly financial results and raised its FY26 sales guidance above estimates. The company reported a second-quarter loss o...
08-08 03:35
财报速睇 | Natera 2026财年Q2营收7.53亿美元，同比增长37.7%；归母净利润亏损0.67亿美元，同比亏损缩窄33.7%
华盛资讯8月7日讯，Natera公布2026财年Q2业绩，公司Q2营收7.53亿美元，同比增长37.7%，归母净利润亏损0.67亿美元，同比亏损缩窄33.7%。
08-07 18:32
美股盘后 | Atlassian暴升32.96%，Cloudflare暴升17.88%
Atlassian暴升32.96%；Cloudflare暴升17.88%；Twilio暴升16.46%
08-07 06:10
Natera Submits Application To Japan’s Pharmaceuticals And Medical Devices Agency For Approval Of The Signatera Test In Muscle-Invasive Bladder Cancer As A Companion Diagnostic
The submission advances Natera’s growing presence in Japan, where Signatera received PMDA approval in colorectal cancer in June, becoming the country’s first PMDA-approved molecular residual disease (MRD) test. The MIBC application is supported by data from IMvigor011, a randomized, double-blind Pha...
08-05 18:09
Cathie Wood's Ark Invest boosts stakes in Tesla, SpaceX, Meta, trimming Figma, Shopify
Cathie Wood’s ARK Invest’s largest purchase during July 20-24 was Tesla (TSLA), with the firm acquiring an additional $52.7M stake after a steep sell-off post weaker-than-expected Q2 earnings report. ...
07-27 19:05
美股大行评级 | 美银上调AMD目标价从550美元升至620美元；IBM暴跌25%！大摩上调目标价升至293美元，汇丰下调评级至"卖出"目标价降至191美元
今日重点评级关注：Keybanc：维持迈威尔科技"超配"评级，目标价从385美元升至400美元；丰业银行：维持科尔黛伦矿业"跑赢大市"评级，目标价从27.5美元升至28.5美元
07-15 10:22
Canaccord Genuity Maintains Buy on Natera, Raises Price Target to $330
Canaccord Genuity analyst Kyle Mikson maintains Natera (NASDAQ:NTRA) with a Buy and raises the price target from $285 to $330.
07-14 19:57
美股大行评级 | 潜在涨幅246.92%！HC Wainwright & Co.上调Rockwell Medical(RMTI)目标价至20美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Rockwell Medical"买入"评级，目标价从2美元升至20美元；Canaccord Genuity：维持创力"买入"评级，目标价从10.5美元升至11美元
07-10 17:36
